Commentary
Funding research to change lives: exploring the impact of Diabetes UK research
E. Robertson, E. Burns,
Corresponding Author
E. Burns
Diabetes UK, London, UK
Correspondence to: Emily Burns. E-mail: [email protected]Search for more papers by this authorE. Robertson, E. Burns,
Corresponding Author
E. Burns
Diabetes UK, London, UK
Correspondence to: Emily Burns. E-mail: [email protected]Search for more papers by this authorNo abstract is available for this article.
References
- 1 Diabetes UK. Our Research Strategy 2015-2019. Diabetes UK, 2015.
- 2Begum M, Lewison G, Sommariva S, Ciani O, Tarricone R, Sullivan R. European diabetes research and its funding, 2002-2013. Diabet Med 2017; 34: 1354–1360.
- 3Paton JS, Wilson M, Ireland JT, Reith SBM. Convenient Pocket Insulin Syringe. Lancet 1981; 317: 189–190.
10.1016/S0140-6736(81)90063-5 Google Scholar
- 4Cass AE, Davis G, Francis GD, Allen H, Hill O, Aston WJ et al. Ferrocene-mediated enzyme electrode for amperometric determination of glucose. Anal Chem 1984; 56: 667–671.
- 5Pickup JC, Keen H, Parsons JA, Alberti KG. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. BMJ 1987; 1: 204–207.
10.1136/bmj.1.6107.204 Google Scholar
- 6Leelarathna L, Dellweg S, Mader JK, Allen JM, Benesch C, Doll W et al. Day and Night Home Closed-Loop Insulin Delivery in Adults With Type 1 Diabetes: Three-Center Randomized Crossover Study. Diabetes Care 2014; 37: 1931–1937.
- 7Stewart ZA, Wilinska ME, Hartnell S, Temple RC, Rayman G, Stanley KP et al. Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes. NEJM 2016; 375: 644–654.
- 8 DAFNE Study Group, Amiel S. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002; 13: 197–204.
- 9Sharp CL, Butterfield WJ, Keen H. Diabetes Survey in Bedford 1962. Proc R Soc Med 1964; 57: 193–204.
- 10 UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–853.
- 11Taylor R, Lovelock L, Tunbridge WMG, Alberti KG, Brackenridge RG, Stephenson P, Young E. Comparison of non-mydriatic retinal photography with ophthalmoscopy in 2159 patients: mobile retinal camera study. BMJ 1990; 301: 1243–1247.
- 12Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364: 685–696.
- 13Edmonds ME, Blundell MP, Morris ME, Thomas EM, Cotton LT, Watkins PJ. Improved survival of the diabetic foot: the role of a specialized foot clinic. London QJ Med 1986; 60: 763–771.
Citing Literature
